DEC 14, 2017 06:00 AM PST
WEBINAR: Laboratory Diagnosis of von Willebrand Disease (VWD)
SPONSORED BY: Abbott Diagnostics
CONTINUING EDUCATION (CME/CE/CEU) CREDITS: P.A.C.E. CE | Florida CE
6 5 1384

Speakers:
  • Manager, Medical and Scientific Affairs, Hematology, Abbott Diagnostics
    Biography
      Dr. Larry Smith received his doctorate in biological sciences from Fordham University, Bronx, New York, and completed his certificate in molecular laboratory diagnostics at Michigan State University, East Lansing, Michigan. He completed his postdoctoral studies in gene therapy and experimental hematopoiesis at Columbia University College of Physicians and Surgeons, New York, New York, and was a research fellow in immunology at Fordham University and at the Laboratory of Lymphokine Biology at the New York Blood Center's Lindsley F. Kimball Research Institute, New York, New York. In addition, Dr. Smith has a Master of Science in medical biology and a Bachelor of Science in French and biology.

      His former positions include Research Associate and Director of the Stem Cell Research Laboratory, Division of Hematology-Oncology, at Long Island College Hospital, Brooklyn, New York; Adjunct Associate Professor at Rutgers School of Health Related Professions, Newark, New Jersey; Adjunct Professor at the School of Health Sciences and Professional Programs, York College, City University of New York, Jamaica, New York; and Director of the Coagulation and Hemostasis Laboratories, Assistant Attending Laboratory Scientist for the Department of Clinical Laboratories, and Associate Director of Clinical Hematology Laboratories at Memorial Sloan Kettering Cancer Center, New York, New York.

      Dr. Smith is a member of the American Association for Clinical Chemistry, the Academy of Clinical Laboratory Physicians and Scientists, the American Society for Clinical Pathology, the American Society of Clinical Laboratory Science, the American Society of Hematology, the International Academy of Clinical and Applied Thrombosis/Hemostasis, the International Society for Laboratory Hematology, and the International Society on Thrombosis and Hemostasis.

      Dr. Smith holds multiple board certificates and has published numerous peer-reviewed articles, abstracts, reviews and monographs. He is the co-author of several textbooks on hematology and coagulation and has been an invited presenter at both national and international conferences. His research interests include laboratory test development for hemostasis and coagulation, HPC therapeutic applications, and flow cytometry.

    Abstract:

    DATE: December 14, 2017
    TIME: 06:00am PST, 09:00am EST, 3:00pm CET

    von Willebrand Disease (vWD) is one of the most common congenital bleeding disorders, affecting ~1%* of the world’s population. An accurate diagnosis can be very challenging due to the heterogeneity of the disorder and preanalytical variables that may affect the assays used in the diagnosis. Clinical laboratories may perform both screening and complex assays to measure different properties and activities of von Willebrand factor (vWF) to aid clinicians with diagnosis. However, these assays may be adversely affected by preanalytical variables and often have altered performance characteristics that may contribute to inadequate interpretation.

    In this webinar, Dr. Larry Smith, Abbott’s coagulation expert with over 30 years of clinical laboratory experience, will:

    • Define vWD and its history
    • Go over current classification of vWD and assays utilized
    • Review structure and function of vWF
    • Discuss methods/technologies for diagnosing vWD, assay limitations, and preanalytical variables influencing vWD testing and interpretation

     

    Don’t miss a future webinar. Sign up today to receive updates.

     

    *Source: World Federation of Hemophilia.

     


    Show Resources
    Loading Comments...